This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Inventor Spotlight: Christoph Faeh
Introduction: Christoph Faeh, a talented inventor based in Zurich, Switzerland, has made significant contributions to the field of pharmaceuticals with his innovative patent on Heteroaryl and benzyl amide compounds. Let's delve into his achievements and career highlights.
Latest Patents: Christoph Faeh holds a notable patent for Heteroaryl and benzyl amide compounds, which includes processes for their preparation, their use as pharmaceuticals, and pharmaceutical compositions comprising them. This patent showcases his expertise in developing novel compounds with potential therapeutic applications.
Career Highlights: Christoph Faeh is affiliated with Hoffmann-La Roche Inc., a renowned pharmaceutical company known for its groundbreaking research and development in the healthcare industry. His association with Hoffmann-La Roche Inc. demonstrates his commitment to pushing the boundaries of pharmaceutical innovation.
Collaborations: Throughout his career, Christoph Faeh has collaborated with esteemed colleagues such as Holger Kuehne and Thomas Luebbers. These collaborations have fostered a stimulating environment for the exchange of ideas and the development of cutting-edge pharmaceutical solutions.
Conclusion: In conclusion, Christoph Faeh stands out as a distinguished inventor in the realm of pharmaceuticals, with his groundbreaking patent on Heteroaryl and benzyl amide compounds. His contributions to the field exemplify his dedication to driving innovation and shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile